# MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer

> **NCT07692230** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fudan University** · enrollment: 2000 (estimated)

## Conditions studied

- HR Positive/HER-2 Negative Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07692230
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-06
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692230, "MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*